Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy-Reference-Cited by-同舟云学术

Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy

Published:2019 Issue:4 Volume:62 Page:285
ISSN:2287-8572
Container-title:Obstetrics & Gynecology Science
language:en
Short-container-title:Obstet Gynecol Sci

Author:

Hue Hyejeong¹,Kim Kidong²^ORCID,Kim HyoJin³,Suh Dong Hoon²,No Jae Hong²,Kim Yong Beom²

Affiliation:

1. Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea.

2. Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.

3. Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.

Publisher

Korean Society of Obstetrics and Gynecology

Subject

Obstetrics and Gynecology

Link

https://synapse.koreamed.org/pdf/10.5468/ogs.2019.62.4.285

Reference15 articles.

1. Prediction of Cancer Incidence and Mortality in Korea, 2018

2. Statistics Korea. Cancer registry statistics [Internet]. Daejeon. Statistics Korea. 2018. cited 2018 Feb 8. Available from: http://kosis.kr

3. Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic Disease

4. Intraperitoneal chemotherapy in advanced ovarian cancer: recognition at last

5. Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conventional peritoneal cytology lacks the prognostic significance of detecting local or peritoneal recurrence in colorectal cancer: An Egyptian experience;JGH Open;2020-12-29